Fermented Foods for Immune Function

Roughly 70% of the body's immune tissue lives in or adjacent to the gut. The gut-associated lymphoid tissue (GALT) interfaces directly with the microbial community on the other side of a single epithelial cell layer, and the signaling that crosses that interface modulates inflammation, antibody production, T-cell differentiation, and tolerance throughout the body. Fermented foods affect every layer of that system. The Wastyk 2021 Stanford trial published in Cell measured a startling drop in 19 of 93 inflammatory proteins — including IL-6, the most consistently elevated cytokine in chronic disease and aging — after ten weeks of six daily fermented food servings. This page walks through the gut-immune axis mechanisms, the specific cytokines that moved in the trial, the relationship to traditional folk-immune wisdom (sauerkraut for colds, kefir for postpartum recovery, miso at the first sign of illness), and the SCFA-Treg-IgA axis that ties it all together.

Table of Contents

  1. The Gut-Immune Axis — Why 70% of Immune Tissue Lives Here
  2. The 19 Cytokines That Dropped in the Wastyk Trial
  3. IL-6 and Chronic Inflammaging
  4. The SCFA-Treg Axis
  5. Mucosal IgA and the Antibody Response
  6. Bacteriocins and Pathogen Resistance
  7. Traditional Folk Immune-Boost Practices
  8. Sauerkraut Juice for Colds (the Cook's Vitamin C)
  9. Kefir for Postpartum Recovery
  10. Miso Soup at the First Sign of Illness
  11. Fermented Foods, Allergy, and Atopic Disease
  12. Fermented Foods and Autoimmunity
  13. Cautions and Caveats
  14. Key Research Papers
  15. Connections

The Gut-Immune Axis — Why 70% of Immune Tissue Lives Here

The gut is the largest immune organ in the body. The gut-associated lymphoid tissue (GALT) includes Peyer's patches in the small intestine, mesenteric lymph nodes, isolated lymphoid follicles, and the lamina propria filled with B cells, T cells, dendritic cells, macrophages, and innate lymphoid cells. Estimates vary, but most immunologists agree that roughly 70% of the body's immune cells reside in or adjacent to the gut. This is not an accident of evolution — it reflects the magnitude of the immunological challenge.

The gut interfaces with the outside world through a single epithelial cell layer. On one side of that layer: 100 trillion microbes (more than the number of cells in the human body), plus a continuous stream of dietary antigens, dietary toxins, and the occasional pathogen. On the other side: the bloodstream and the rest of the body. The immune system must simultaneously tolerate commensal bacteria and food antigens (otherwise the body would mount a continuous, fatal inflammatory response to lunch) while attacking pathogens. The decision of whether a given organism on the luminal side is "self-with-microbes" (tolerate) or "foreign threat" (attack) is made minute by minute by the GALT.

Fermented foods affect this decision-making in several ways:

The cumulative effect is a more regulated immune system — not more active in absolute terms, but more appropriately deployed, with less low-grade chronic inflammation in the periphery. The Wastyk trial cytokine results directly demonstrate this regulation.

Back to Table of Contents

The 19 Cytokines That Dropped in the Wastyk Trial

The Wastyk 2021 paper measured 93 inflammatory proteins in serum at baseline and at the end of the ten-week intervention. In the fermented foods arm, 19 of those 93 proteins decreased significantly. The decreases were concentrated in inflammatory cytokines and chemokines associated with chronic low-grade inflammation, the "inflammaging" pattern linked to cardiovascular disease, type 2 diabetes, neurodegeneration, and accelerated biological aging.

The most notable signals included:

Importantly, the trial did not see decreases in protective antibody responses or in cytokines associated with adaptive immune competence. This is the right pattern: reduce chronic low-grade inflammation while preserving the ability to mount a focused response when needed. The high-fiber arm of the trial did not produce the cytokine decreases, which suggests the live-cell + postbiotic delivery of fermented foods is doing immune work that pure substrate (fiber) does not.

One nuance: the Wastyk trial was done in healthy adults without active disease. Translating the cytokine results to a person with established chronic inflammation (rheumatoid arthritis, IBD, atherosclerosis) requires careful clinical judgment. The mechanism is plausible and the direction is favorable, but the effect size in disease states has not yet been measured in equivalently rigorous trials.

Back to Table of Contents

IL-6 and Chronic Inflammaging

IL-6 deserves special attention because it is the most reliable single biomarker of "inflammaging" — the chronic low-grade systemic inflammation that accumulates with age and drives many of the diseases of aging. Elevated baseline IL-6 predicts cardiovascular events, type 2 diabetes onset, sarcopenia, frailty, cognitive decline, and all-cause mortality across multiple longitudinal cohort studies. IL-6 is also the target of several FDA-approved biologic drugs (tocilizumab, sarilumab) used for rheumatoid arthritis and giant cell arteritis — an indicator of how seriously the cytokine is taken as a driver of disease.

The mechanism of IL-6 elevation in aging is multifactorial. Senescent cells secrete IL-6 as part of the senescence-associated secretory phenotype (SASP). Adipose tissue, especially visceral fat, is a major IL-6 source. Chronic infection (cytomegalovirus, periodontal disease, urinary tract colonization) drives IL-6. And gut dysbiosis — loss of microbiome diversity, increased gut permeability, low-grade endotoxemia from translocation of gram-negative bacterial lipopolysaccharide — is another well-documented source.

Fermented foods address the gut-source contribution to IL-6 elevation by improving epithelial barrier integrity (reducing endotoxin translocation), increasing diversity (reducing the proportion of pro-inflammatory gram-negative species), and providing SCFAs (which signal through GPR43 to suppress NF-kB activation, the master switch for inflammatory cytokine transcription). The Wastyk trial result of a measurable IL-6 decrease in healthy adults after ten weeks suggests this mechanism is clinically operative even in people who do not start out with frank disease.

Back to Table of Contents

The SCFA-Treg Axis

Short-chain fatty acids (SCFAs) — acetate, propionate, and butyrate — are the most-studied class of microbial metabolite. They are produced in the colon by bacterial fermentation of dietary fiber, and they are also delivered directly by certain fermented foods (lactate and acetate in particular). Butyrate is the principal energy substrate of colonocytes (cells lining the colon take up butyrate preferentially as fuel) and is the most biologically active SCFA across multiple measured outcomes.

The SCFA-Treg axis works as follows. SCFAs cross from the gut lumen into colonic tissue and into circulation. There they bind G-protein-coupled receptors (GPR41, GPR43, GPR109A) on immune cells and act as histone deacetylase (HDAC) inhibitors. The combined effect is to drive naive CD4+ T cells toward the regulatory T cell (Treg) phenotype, which is characterized by expression of the transcription factor FoxP3 and secretion of the anti-inflammatory cytokines IL-10 and TGF-beta.

Tregs are the immune system's brakes. They suppress effector T cells, dampen autoimmunity, maintain tolerance to commensal bacteria and food antigens, and limit collateral tissue damage during infection. Loss of Tregs (genetic, pharmacological, or disease-driven) produces severe autoimmunity. The IPEX syndrome, caused by mutations in FoxP3, is a fatal childhood condition of multi-system autoimmunity that demonstrates the necessity of functional Tregs for normal life.

Fermented foods feed the SCFA-Treg axis from two directions. The bacterial cells in the ferments produce SCFAs directly. The fiber matrix of fermented vegetables feeds the resident gut bacteria that produce more SCFAs in the colon. The result is sustained substrate for Treg induction throughout the day, which over weeks shifts the steady-state Treg-to-effector-T-cell ratio toward tolerance and away from inflammation.

For the broader gut-brain implications of SCFAs (vagal afferent signaling, microglial regulation, neurogenesis effects), see our Gut-Brain Axis page.

Back to Table of Contents

Mucosal IgA and the Antibody Response

Secretory IgA is the dominant antibody class on mucosal surfaces, including the gut lumen. Dimeric IgA molecules are secreted by plasma cells in the lamina propria and transported across the epithelium by the polymeric immunoglobulin receptor (pIgR), which releases them into the lumen as secretory IgA (sIgA). The sIgA antibodies bind to bacterial and viral antigens, prevent attachment to the epithelium, and neutralize toxins — all without provoking inflammation, in contrast to systemic IgG responses.

The B cells that produce IgA require both TGF-beta and retinoic acid as co-signals for class switching. Fermented foods contribute to this through two mechanisms: SCFAs (which support the Treg-derived TGF-beta) and direct microbial signaling that increases B-cell trafficking to the gut. Probiotic Lactobacillus and Bifidobacterium strains have been shown in multiple studies to increase fecal and salivary sIgA in healthy human subjects, with effect sizes typically in the 30–100% range.

The clinical relevance of elevated sIgA: protection against respiratory and gastrointestinal infection (which begins on mucosal surfaces), reduced food allergy sensitization (sIgA binds food antigens before they cross the epithelium and trigger systemic IgE responses), and protection against opportunistic gut pathogens. Breastfeeding mothers transfer sIgA to nursing infants through breast milk, and maternal fermented food intake correlates with infant gut microbiome development in observational studies.

Back to Table of Contents

Bacteriocins and Pathogen Resistance

Bacteriocins are narrow-spectrum antimicrobial peptides produced by bacteria, often targeting closely related species or specific pathogens. Lactic acid bacteria are particularly prolific bacteriocin producers, which is part of why fermented foods are biologically self-preserving (the bacteriocins suppress spoilage organisms, allowing the ferment to remain shelf-stable for months).

The bacteriocins consumed in fermented foods include:

In the gut, these bacteriocins persist transiently and contribute to pathogen exclusion. They also work synergistically with the live ferment cells, which compete with pathogens for adhesion sites on the epithelium and for nutrient substrates. The combined effect is colonization resistance against opportunistic enteric pathogens such as Salmonella, Listeria, enterohemorrhagic E. coli, and Clostridioides difficile.

The clinical demonstration of this is most striking in C. difficile infection, where restoring microbiome diversity (via fecal transplant or aggressive probiotic intake) reverses what antibiotic regimens often cannot. While fermented foods are not a substitute for established C. difficile treatment, they appear to reduce the risk of C. difficile colitis in elderly hospitalized patients in observational studies. The mechanism is the same colonization resistance.

Back to Table of Contents

Traditional Folk Immune-Boost Practices

Long before modern immunology mapped the cytokine networks, traditional cultures intuitively associated fermented foods with immune function. The associations were often correct, sometimes with mechanism only confirmed by modern research a century later. A partial catalog:

The Metchnikoff hypothesis (1907) is worth noting in particular. Elie Metchnikoff, the Nobel laureate immunologist who discovered phagocytosis, observed that Bulgarian peasants who consumed large amounts of fermented yogurt had unusually long lifespans. He hypothesized that the Lactobacillus bulgaricus in the yogurt was responsible — an early articulation of the probiotic concept. While Metchnikoff overstated the case (Bulgarian longevity has many contributors and was likely partly an artifact of incomplete birth registration), his core intuition that gut bacteria affect systemic health has been spectacularly confirmed by a century of subsequent research.

Back to Table of Contents

Sauerkraut Juice for Colds (the Cook's Vitamin C)

Sauerkraut occupies a notable place in maritime medical history. Captain James Cook's second voyage of HMS Resolution from 1772 to 1775 famously had no deaths from scurvy — an unprecedented record for a three-year voyage at the time — in part because Cook insisted on the ship being provisioned with large quantities of sauerkraut. Cook had read the work of James Lind and was experimenting with multiple antiscorbutic strategies including malt, citrus, and sauerkraut. The sauerkraut worked well enough that the Royal Navy adopted it as standard issue.

The biochemistry is clear in retrospect. Vitamin C is heat-labile and is destroyed by cooking, but lacto-fermentation preserves it (the cool, anaerobic, low-pH fermentation environment is gentle on ascorbate). A cup of fresh raw sauerkraut delivers roughly 15–20 mg of vitamin C, which is meaningful when the alternative on a long voyage is cooked vegetables with the vitamin C destroyed. Beyond the vitamin C contribution, sauerkraut provides live Lactobacillus cultures, glucosinolate-derived isothiocyanates (sulforaphane and indole-3-carbinol from the cabbage), and fiber.

In Germanic and Eastern European folk medicine, the brine from a fresh sauerkraut crock was considered the most therapeutic part, and was drunk by tablespoonful at the first sign of a cold. The brine is concentrated in bacterial metabolites and bacteriocins. There is no rigorous randomized trial of sauerkraut juice for colds — but the mechanism (mucosal IgA support, vitamin C delivery, immunomodulation by Lactobacillus) is plausible.

Back to Table of Contents

Kefir for Postpartum Recovery

In the Caucasus mountain cultures where kefir originated — Georgia, Armenia, Azerbaijan, and the surrounding regions — kefir was traditionally considered medicinal, with specific use cases including postpartum recovery, infant feeding, and convalescence from illness. The Caucasian view was that kefir restored vitality, supported milk production in nursing mothers, and was gentle enough to feed to infants weaning off the breast.

Modern microbiology has somewhat vindicated these traditional uses. Kefir is a polymicrobial ferment with 30+ species of Lactobacillus, Lactococcus, Leuconostoc, Acetobacter, and yeasts including Saccharomyces cerevisiae. This species diversity is far greater than any single yogurt. Kefir contains kefiran (an exopolysaccharide with immunomodulatory and anti-tumor activity demonstrated in animal studies), CLA (conjugated linoleic acid from the bacterial metabolism of milk fat), and a range of bioactive peptides released during the milk-protein fermentation.

The postpartum-recovery use case is reasonable for several reasons: the protein and fat content support recovery from the metabolic demands of childbirth; the live cultures support both maternal and (via breast milk) infant gut establishment; the lower lactose content compared to fresh milk is easier on lactose-intolerant mothers; and the immune-modulating peptides may support the transition from the pregnancy-induced Th2-skewed immune state back to balanced immunity.

Back to Table of Contents

Miso Soup at the First Sign of Illness

Japanese household practice has long been to drink miso soup at the first sign of illness — a cold, stomach upset, general malaise. The practice is so ingrained that miso soup is the standard hospital breakfast in many Japanese institutions. The mechanism is multifactorial: the warm broth supports fluid intake and electrolyte balance; the live cultures in unpasteurized miso provide immune-modulating Lactobacillus and yeast cells; the isoflavones from the soybean substrate have mild immunomodulating effects; and the dashi base contributes glutamate (umami flavor that drives caloric intake when illness has reduced appetite).

The choice of miso matters. Traditional unpasteurized miso (often called "raw" miso) contains live Aspergillus oryzae mold cultures plus Lactobacillus and yeasts. Modern commercial misos are often pasteurized for shelf stability, which kills the cultures but preserves the postbiotic content (peptides, organic acids, isoflavone aglycones). Both forms have value; unpasteurized is the richer of the two.

A practical detail: miso should be added to soup off the heat. Boiling miso destroys the heat-sensitive live cultures and degrades the delicate flavor compounds. The traditional method is to dissolve a tablespoon of miso paste in a small ladle of warm dashi off the burner, then stir it back into the larger pot.

Back to Table of Contents

Fermented Foods, Allergy, and Atopic Disease

The "hygiene hypothesis" and its refinement to the "old friends" or "biodiversity" hypothesis hold that early-life under-exposure to environmental and gut microbes contributes to the modern rise in allergies, asthma, atopic dermatitis, and food allergies. Fermented foods fit naturally into this framework as a source of bacterial diversity for early-life gut establishment.

Several lines of evidence support a protective role:

The mechanism centers on Treg induction and oral tolerance. The fermented-food bacteria signal through epithelial pattern-recognition receptors in a way that promotes Treg differentiation, which in turn maintains tolerance to food antigens that would otherwise trigger IgE-mediated sensitization. The SCFA-Treg axis (discussed above) is the dominant proposed mechanism.

For established food allergies, fermented foods are not a treatment. Patients with severe IgE-mediated food allergies should never use fermented foods as a desensitization strategy — oral immunotherapy is a different, medically supervised intervention. But for the broader population trying to maintain a regulated immune system, the role of fermented foods in tolerance induction is well-supported.

Back to Table of Contents

Fermented Foods and Autoimmunity

The role of fermented foods in autoimmune disease is an active research area with hints of benefit but no definitive randomized trials. The theoretical case is strong: autoimmunity is fundamentally a Treg deficit (or a regulatory T cell that is being outcompeted by inappropriate effector responses), and the SCFA-Treg-IgA axis that fermented foods feed is the most basic Treg-supporting pathway available.

Conditions where fermented foods have plausible benefit:

The caveat is that fermented foods are not a substitute for established autoimmune disease management. Disease-modifying drugs, biologics, and other immune-targeted therapies remain the standard of care. Fermented foods are an adjunct — potentially valuable, generally safe, but not curative on their own.

Back to Table of Contents

Cautions and Caveats

Back to Table of Contents

Key Research Papers

  1. Wastyk HC et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell 184(16):4137-4153. — PubMed
  2. Marco ML et al. (2017). Health benefits of fermented foods: microbiota and beyond. Current Opinion in Biotechnology 44:94-102. — PubMed
  3. Arpaia N et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451-455. — PubMed
  4. Smith PM et al. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569-573. — PubMed
  5. Maslowski KM et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282-1286. — PubMed
  6. Furusawa Y et al. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446-450. — PubMed
  7. Metchnikoff E (1907). The Prolongation of Life: Optimistic Studies. (historical foundational text on the gut microbiome and longevity) — PubMed
  8. Hill C et al. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. — PubMed
  9. Round JL, Mazmanian SK (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. — PubMed
  10. Belkaid Y, Hand TW (2014). Role of the microbiota in immunity and inflammation. Cell 157(1):121-141. — PubMed
  11. Park S et al. (2014). A randomized clinical trial of kimchi intake on cardiovascular and metabolic indicators. Nutr Res. — PubMed
  12. Bordoni A et al. (2017). Dairy products and inflammation: A review of the clinical evidence. Crit Rev Food Sci Nutr. — PubMed
  13. Plovier H et al. (2017). A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents